Lara Adejoro, Abuja – The World Health Organization (WHO) estimates that about one in every 100 children has an autism spectrum disorder (ASD), a diverse group of conditions affecting brain development. This figure represents an average; prevalence rates vary widely across studies, and some well‑controlled research reports considerably higher numbers. In many low‑ and middle‑income countries, the prevalence of autism remains unknown.
ASDs are characterized by difficulties with social interaction and communication, as well as atypical patterns of activity and behavior. These may include challenges in transitioning between tasks, a focus on details, and unusual sensory reactions. The abilities and needs of autistic individuals differ greatly and can change over time. While some people with autism can live independently, others experience severe disabilities that require lifelong care and support. Autism often impacts educational and employment opportunities, and the demands on families providing care can be substantial. Societal attitudes and the level of support from local and national authorities are crucial determinants of quality of life for people with autism.
Characteristics of autism may be detectable in early childhood, yet diagnosis frequently occurs much later. Many autistic individuals have co‑occurring conditions such as epilepsy, depression, anxiety, attention‑deficit/hyperactivity disorder, sleep difficulties, and self‑injurious behavior. Intellectual functioning among autistic people spans a broad spectrum, from profound impairment to superior abilities.
Scientific evidence suggests that multiple factors—both environmental and genetic—may increase a child’s likelihood of developing autism. Epidemiological data show no causal link between the measles, mumps, and rubella (MMR) vaccine and autism; earlier studies suggesting such a link were methodologically flawed. Likewise, there is no evidence that any other childhood vaccine raises autism risk. Reviews of the preservative thimerosal and aluminum adjuvants in inactivated vaccines also conclude that vaccines do not increase autism risk.
The WHO emphasizes that a wide range of interventions, from early childhood through the lifespan, can optimize development, health, well‑being, and quality of life for autistic individuals. Although people with autism have the right to the highest attainable standard of physical and mental health, they often face stigma and discrimination, including unjust denial of health care, education, and opportunities to engage fully in their communities.
Comments are closed for this story.